These PD-L1+TAMs, activated by tumor-derived IL-10, have been proposed to mediate CD8+ T cell dysfunction through the PD-1/PD-L1 interaction (Kuang et al., 2009; Wu et al., 2009). Here, IL10 is linked to neoplasm.